|
Volumn 28, Issue 3, 1997, Pages 476-481
|
Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria
a a a a a b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMALARIAL AGENT;
ARTEMETHER PLUS BENFLUMETOL;
ARTEMISININ DERIVATIVE;
CHLOROQUINE;
FLUORENE DERIVATIVE;
SESQUITERPENE;
ADOLESCENT;
ADULT;
ARTICLE;
CHINA;
CLINICAL TRIAL;
DRUG COMBINATION;
DRUG RESISTANCE;
FEMALE;
HUMAN;
MALARIA FALCIPARUM;
MALE;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PARASITOLOGY;
PHASE 2 CLINICAL TRIAL;
TIME;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
ANTIMALARIALS;
ARTEMISININS;
CHINA;
CHLOROQUINE;
DRUG COMBINATIONS;
DRUG RESISTANCE;
FEMALE;
FLUORENES;
HUMANS;
MALARIA, FALCIPARUM;
MALE;
MIDDLE AGED;
SESQUITERPENES;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0031219219
PISSN: 01251562
EISSN: 26975718
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (25)
|
References (9)
|